Sudhir Paul

Expression of an anti-beta-amyloid catalytic antibody by AAV9-mediated gene delivery effectively prevents and reduces amyloid deposition in an Alzheimer's disease mouse model

P2-407 EXPRESSION OFAN ANTI-BETA-AMYLOID CATALYTIC ANTIBODY BYAAV9-MEDIATED GENE DELIVERY EFFECTIVELY PREVENTS AND REDUCES AMYLOID DEPOSITION IN AN ALZHEIMER’S DISEASE MOUSE MODEL Jinghong Kou, Junling Yang, Abhinandan Pattanayak, Min Song, Stephanie Planque, Sudhir Paul, Ken-ichiro Fukuchi, University of Illinois College of Medicine at Peoria, Peoria, Illinois, United States; University of Texas Health Science Center-Medical School at Houston, Houston, Texas, United States. Contact e-mail: kfukuchi@uic.edu

Beneficial catalytic autoimmunity to beta-amyloid peptide

BETA-AMYLOID PEPTIDE Yasuhiro Nishiyama, Stephanie Planque, Mariko Hara, Kenji Watanabe, Xiaoyun Xu, Hiroaki Taguchi, Einar M. Sigurdsson, Brian O’Nuallain, Ian Murray, Robert P. Friedland, Ken-ichiro Fukuchi, Richard Massey, Sudhir Paul, University of Texas Health Science Center-Medical School at Houston, Houston, Texas, United States; University of Texas Health Science Center-Medical School at Houston, Houston, Texas, United States; 3 New York University School of Medicine, New York, New York, United States; Harvard Medical School-Brigham & Womens Hospital, Boston, Massachusetts, United States; Texas A&M Health Science Center, Bryan, Texas, United States; 6 University of Louisville, Louisville, Kentucky, United States; 7 University of Illinois College of Medicine at Peoria, Peoria, Illinois, United States; Covalent Bioscience, Inc., Houston, Texas, United States.